Cue Biopharma, INC. (CUE) SEC Filings — 2025
16 SEC filings for Cue Biopharma, INC. (CUE) in 2025.
Filings
- Cue Biopharma Files 8-K: Material Agreement, Other Events — 8-K · Dec 19, 2025
- Cue Biopharma, INC. 8-K Filing — 8-K · Nov 24, 2025
- Cue Biopharma Announces Board Changes and Officer Compensation Updates — 8-K · Nov 20, 2025
- Cue Biopharma Narrows Losses, Boosts Cash with ImmunoScape Deal — 10-Q · Nov 12, 2025
- Cue Biopharma Files 8-K: Material Agreement, Financials — 8-K · Nov 6, 2025
- Cue Biopharma Announces Board and Officer Changes — 8-K · Sep 29, 2025
- Cue Biopharma Narrows Q2 Loss Amidst Zero Revenue — 10-Q · Aug 12, 2025
- Cue Biopharma Enters Material Definitive Agreement — 8-K · Jul 1, 2025
- Cue Biopharma Reports Director/Officer Changes & Corporate Updates — 8-K · Jun 10, 2025
- Cue Biopharma Files Proxy Materials — DEFA14A · May 27, 2025
- Cue Biopharma Files Q1 2025 10-Q, Cites Warrant Activity — 10-Q · May 12, 2025
- Cue Biopharma Executive Compensation Details Released — DEF 14A · Apr 25, 2025
- Cue Biopharma Files 8-K on Material Agreement — 8-K · Apr 15, 2025
- Cue Biopharma Enters Material Definitive Agreement — 8-K · Apr 14, 2025
- Cue Biopharma, INC. 10-K Filing — 10-K · Mar 31, 2025
- Cue Biopharma Announces Board and Executive Changes — 8-K · Mar 12, 2025